Huntington's Disease (HD) is a heritable genetic disease that is neurodegenerative in nature. It impacts every aspect of the human condition -- the physical (muscular), the mental (memory and cognition), and behavior (mood). The onset of the disease varies with the majority of cases appearing in adults. As it is a genetic disease that is caused when genes are inherited, all persons who have the defective gene in their bodies act as carriers and may pass it on to offspring. Thus, a copy of a defective Huntington gene is the culprit, and when genes are passed down through the generations, one defect is all that is needed in order for an individual to develop the disease. Once the gene is possessed, onset at some point is certain, as the "monogenetic etiology" consists of a single defective inherited gene that needs no other external factors or variants for causation (Lu, Yang, p. 964, 2012). This paper will discuss the nature of Huntington's Disease and the state of research on it today.
The disease process usually onsets in middle age, with symptoms ranging from feelings of "clumsiness" to "balance trouble" (Margolis, Ross, 2003, p. 1726). These symptoms are typically accompanied by cognitive disruptions. Mood disorders are also commonly associated with the onset of HD. Once onset begins, the disease progresses and is fatal. Predisposing factors are simply the possession of the defective Huntington gene. There is currently no prophylaxis nor method of prevention for the disease as it is incurable. However, studies are being performed in which therapies are being tested for alleviation of symptoms (Lu, Yang, 2012). These studies include antisense therapy and the "sustained benefit of transient mHtt lowering" (Lu, Yang, 2012). While it is unknown why or how this therapy works, it is assessed that relief of the symptoms is the result.
HD is still a relatively mysterious phenomenon. The pathogenesis of HD is not exactly clear with various researchers offering different theories about how the disease progresses (Landles, Bates, 2004). However, the causative effects have been identified by Lu and Yang (2012) as beginning with a "CAG expansion encoding an elongated polyglutamine (polyQ) repeat near the N terminus of the Huntingtin (Htt) protein," though it is still uncertain how these molecules interact and function (p. 965). The temporal nature of the onset can be latent for many years and depends on the repetitions of the CAG, but it has been "seen in individuals with a juvenile onset" (Kojovic, Cordivari, Bhatia, 2011, p. 50). Once the disease is onset in the middle age, however, the temporal progress is acute, with precipitating factors being determined on a body by body basis, with the normal onset occurring around age 40, in men and women alike and irrespective of race (Lu, Yang, 2012)
The CAG trinucleotide repeat is the segment that is involved in the HTT gene that is defective and it consists of a DNA series that repeats over a number of times. In a normal CAG segment, the repeat is anywhere from 10 to 35 times. Huntington's Disease is characterized by a repeat that is anywhere from 36 to 120 times. Individuals with fewer repeats (in the 36 to 40 range) many not show or develop any signs or symptoms of HD, though individuals with over 40 repeats typically do show signs and symptoms of the disorder and impacted most heavily by it (Warby, Graham, Hayden, 2014).
The manifestations of Huntington's Disease include moodiness, irritability, inability to function normally, a loss of short-term memory, a fumbling of objections and a loss of coordination. Because it is a neurological disease that impacts the brain, the nervous system is affected as a result and degeneration of the body's ability to behave normally is the main manifestation. The condition worsens over time and it is expected that the patient will require care, usually being fed by a caretaker, washed, and overseen in this manner (Huntington's Disease, 2013).
According to Stoler and Meltzer (2013) HD "introduces a large and extrogenous risk of early mortality and morbidity" (p. 132). Complications ensue as the disease permeates the "motor, cognitive and psychiatric" processes of the body, thereby impacting virtually every aspect of the person, both in mind and physicality (Stoler, Meltzer, 2013, p. 133). It is thus a bioneurological disorder that has no reverse. The genetic possibility of obtaining Huntington's Disease from a parent who has the defective gene is 50%, as either a copy of the whole gene will be passed or a copy of the defective gene will be passed. As the disease progresses, disability...
Huntington's disease, also known as HD, is an uncommon degenerative disorder that greatly impacts the central nervous system of the individual. It is often characterized by surplus and unneeded choreatic movements, unusual behavioral patterns, disturbances in the mental level and dementia. (Sheth 2013) As far as the Caucasian population is concerned, the Huntington's disease is prevalent in one out of ten thousand persons. The symptoms start to appear when the
Creatine treatment started at 6, 8, and 10 weeks of age, analogous to early, middle, and late stages of human HD, significantly extended survival at both the 6- and 8-week starting points. Significantly improved motor performance was present in both the 6- and 8-week treatment paradigms, while reduced body weight loss was only observed in creatine-supplemented R6/2 mice started at 6 weeks." (Dedeoglu, et al., 2003) Specifically it is
HD is extremely debilitating, and if the patient lives long enough, the symptoms can become extremely severe. It is not uncommon for patients who suffer from the disease to suffer extreme depression and sometimes suicide, so developing medications that could delay or slow the disease are extremely important, and laboratory testing should definitely continue in this area. Laboratory work in the past decades has helped develop a much deeper understanding
Huntington's disease affects families What is Huntington's disease, and how does it affect the patient and his family? How does one deal with the patient? Is there any cure for the disease, and what is it? When was the disease discovered? Who discovered it, and how was it discovered? What way is support offered from external sources for the disease, and how can one avail of the support? What, exactly
In fact, many researchers believed that free radicals, produced when the body burns oxygen to produce energy consumed in food, may be at cause. Free radicals are believed to damage brain cells by taking electrons away from the body's healthy molecules to balance themselves. A few 'free radicals' is not a problem. IF there are too many free radicals, the 'oxidative damage' affects the brain causing AD symptoms (Healing with Nutrition
Huntington's disease (HD) was the first autonomic dominant disorder for which genetic prediction became possible" (Harper, et al., 2000, Journal of Medical Genetics, p. 567). HD is a disease that occurs due to an inherited disorder leading to the death of brain cells. A diagnosis of HD is accomplished through genetic testing which can be implemented at any age regardless of whether the symptoms manifest or not. Although, the specific
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now